DarioHealth Corp. Income Tax Expense
DarioHealth Corp. (DRIO) reported Income Tax Expense of $328.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-11
- DarioHealth Corp. income tax expense (benefit) for the quarter ending 2026-06-30 was $328.00K.
- DarioHealth Corp. income tax expense (benefit) for the quarter ending 2026-03-31 was $57.00K, a 159.09% increase year-over-year.
- DarioHealth Corp. income tax expense (benefit) for the quarter ending 2025-12-31 was $83.00K, a 46.45% decline year-over-year.
- DarioHealth Corp. income tax expense (benefit) for the quarter ending 2025-09-30 was $0.00.
- DarioHealth Corp. income tax expense (benefit) for fiscal 2025 was $105.00K.
- DarioHealth Corp. income tax expense (benefit) for fiscal 2024 was -$1.85M, a 2993.75% decline from fiscal 2023.
- DarioHealth Corp. income tax expense (benefit) for fiscal 2023 was $64.00K, a 1500.00% increase from fiscal 2022.
- DarioHealth Corp. income tax expense (benefit) for fiscal 2022 was $4.00K, a 87.50% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|
| 2026-06-30 | $328.00K 10-Q · filed 2026-08-11 | $384.00K 10-Q · filed 2026-08-11 | $468.00K derived: sum of 3 quarters · filed 2026-08-11 | $468.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2026-03-31 | $57.00K 10-Q · filed 2026-05-13 | $140.00K derived: sum of 2 quarters · filed 2026-05-13 | $140.00K derived: sum of 3 quarters · filed 2026-05-13 | $140.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-12-31 | $83.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $83.00K derived: sum of 2 quarters · filed 2026-03-19 | $83.00K derived: sum of 3 quarters · filed 2026-08-11 | $105.00K 10-K · filed 2026-03-19 | |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-13 | $0.00 derived: sum of 2 quarters · filed 2026-08-11 | $22.00K 10-Q · filed 2025-11-13 | $177.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-06-30 | $0.00 10-Q · filed 2026-08-11 | $22.00K 10-Q · filed 2026-08-11 | $177.00K derived: sum of 3 quarters · filed 2026-08-11 | $164.00K derived: sum of 4 quarters · filed 2026-08-11 | |
| 2025-03-31 | $22.00K 10-Q · filed 2026-05-13 | $177.00K derived: sum of 2 quarters · filed 2026-05-13 | $164.00K derived: sum of 3 quarters · filed 2026-05-13 | -$1.83M derived: sum of 4 quarters · filed 2026-05-13 | |
| 2024-12-31 | $155.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19 | $142.00K derived: sum of 2 quarters · filed 2026-03-19 | -$1.85M derived: sum of 3 quarters · filed 2026-03-19 | -$1.85M 10-K · filed 2026-03-19 | |
| 2024-09-30 | -$13.00K 10-Q · filed 2025-11-13 | -$2.01M derived: sum of 2 quarters · filed 2025-11-13 | -$2.01M 10-Q · filed 2025-11-13 | ||
| 2024-06-30 | -$1.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$1.99M 10-Q · filed 2025-08-12 | |||
| 2024-03-31 | $0.00 10-Q · filed 2025-08-12 | -$1.99M 10-Q · filed 2024-05-15 | |||
| 2023-12-31 | $64.00K 10-K · filed 2025-03-10 | ||||
| 2022-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $3.00K derived: sum of 2 quarters · filed 2024-03-28 | $4.00K derived: sum of 3 quarters · filed 2024-03-28 | $4.00K 10-K · filed 2024-03-28 | |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.00K derived: sum of 2 quarters · filed 2023-11-02 | $1.00K 10-Q · filed 2023-11-02 | ||
| 2022-06-30 | $1.00K 10-Q · filed 2023-08-10 | $1.00K 10-Q · filed 2023-08-10 | |||
| 2021-12-31 | $32.00K 10-K · filed 2023-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B | |
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| LENSAR, Inc. (LNSR) | United States | $0.087B | 2.02 |